To use all functions of this page, please activate cookies in your browser.
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Ariadne (α-Et-DOM), or 4-methyl-2,5-dimethoxy-alpha-ethylphenethylamine, is a lesser-known psychedelic drug. It is an analog of 2C-D and DOM. Ariadne was first synthesized by Alexander Shulgin. In his book PIHKAL (Phenethylamines I Have Known and Loved), Shulgin reported testing Ariadne up to a dose of 32mg, and reported that it produces psychedelia and a bare threshold. Very little data exists about the pharmacological properties, metabolism, and toxicity of Ariadne in humans apart from Shulgin's limited testing.
Additional recommended knowledge
However, in more recent animal studies, α-Et-DOM was shown to produce stimulus generalisation in rats trained to respond to the drug MDMA. This suggests that while α-Et-DOM may lack hallucinogenic effects, it might potentially produce empathogenic effects similar to those of MDMA if used at higher dose ranges, beyond those trialled by Shulgin (the potency of α-Et-DOM in this study was similar to that of MDMA, 1.5mg/kg, which would equate to a dose of ~100mg in a human).
|This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Ariadne_(psychedelic)". A list of authors is available in Wikipedia.|